These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19690493)

  • 1. Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer.
    Wei SC; Liang JT; Tsao PN; Hsieh FJ; Yu SC; Wong JM
    Dis Colon Rectum; 2009 Sep; 52(9):1630-6. PubMed ID: 19690493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
    Werther K; Christensen IJ; Nielsen HJ;
    Br J Cancer; 2002 Feb; 86(3):417-23. PubMed ID: 11875709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum placenta growth factor level as a new marker for stage II or III colorectal cancer patients.
    Kemık O; Sarbay Kemık A; Sümer A; Purısa S; Tükenmez B; Tüzün S
    Turk J Gastroenterol; 2012 Apr; 23(2):104-9. PubMed ID: 22706737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
    Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
    Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
    Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
    Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma.
    Okugawa Y; Miki C; Toiyama Y; Koike Y; Inoue Y; Kusunoki M
    Dis Colon Rectum; 2009 Jul; 52(7):1330-6. PubMed ID: 19571712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K; Christensen IJ; Brünner N; Nielsen HJ
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-6 levels reflect the disease status of colorectal cancer.
    Chung YC; Chang YF
    J Surg Oncol; 2003 Aug; 83(4):222-6. PubMed ID: 12884234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
    Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
    Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
    Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
    Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer.
    Belluco C; Nitti D; Frantz M; Toppan P; Basso D; Plebani M; Lise M; Jessup JM
    Ann Surg Oncol; 2000 Mar; 7(2):133-8. PubMed ID: 10761792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
    Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection.
    Shim KS; Kim KH; Han WS; Park EB
    Cancer; 1999 Feb; 85(3):554-61. PubMed ID: 10091729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
    Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
    Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.